HCPLive Network

Equianalgesic Opioid Dosing Calculation Isn’t Simple Math

Though American Society of Pain Educators Board President Mary Lynn McPherson, PharmD, BCPS, CPE, FASPE, pointed out “people who do brain surgery every day look like deer in the headlights with opioid conversion … when they can ask any third grader how to do it,” her case studies featuring patients with a lack of therapeutic response and numerous adverse events and medical conditions, as well as formulations with different dose infusion rates, required skills in opioid conversion calculation above elementary school level.
After distributing copies of an equianalgesic opioid dosing chart published in her 2008 medical book, Demystifying Opioid Conversion Calculations: A Guide for Effective Dosing, at the start of her PAINWeek 2013 session on opioid conversions, McPherson explained that although the proportion of 30 mg of oral morphine equaling 10 mg of parenteral morphine seems straightforward, the problems with those conversion equations are that they’re accompanied by a mass of footnotes and they don’t take patient characteristics into account — which is why healthcare professionals need to complete the “five-step opioid conversion chart process” before, during, and after the switch to another analgesic.
According to McPherson, the steps of that process involve:
  1. Globally assessing the patient’s pain complaint.
  2. Determining the total daily dose of current long-acting and short-acting opioids.
  3. Deciding which opioid analgesic will be used as the new agent, and then referring to established conversion tables to determine the new dose.
  4. Individualizing the dose based on patient assessment information gathered in the first step.
  5. Continually reassessing the patient through seven to14 days after the initial new dose. Or, as McPherson put it, “follow your patient like it’s nobody’s business.”
 Armed with the chart, the footnotes, and the steps, those in the audience were taken through a problem set of 12 case studies requiring conversions from one oral dosage formulation to another oral dosage formulation; from one route of administration to another route; from one opioid to a different opioid, regardless of opioid formulation; and to and from transdermal opioids.

Further Reading
In the era of rapidly improving cure rates for hepatitis C infection, has the importance of staging as part of treatment diminished?
Study results show that patients suffering from active inflammatory bowel disease (IBD) are at risk for poor prognoses following an initial myocardial infarction.
New research provides some of the first concrete support for a treatment guideline that has long been recommended on grounds of common sense alone: Patients who suffer severe allergic reactions such as anaphylaxis should follow up on their emergency room care by seeing an allergist or immunologist.
Children may be at lower risk of Ebola virus disease, but physicians should be aware of the signs and symptoms, according to a viewpoint piece published online Oct. 17 in JAMA Pediatrics.
Inflammatory bowel diseases have an impact on the prognosis of multiple sclerosis, according to a study published in PLOS One.
The brains of children and adolescents with attention deficit hyperactivity disorder (ADHD) are slower to develop some key connections, according to a study published in the Proceedings of the National Academy of Sciences.
About 6% of US boys are circumcised later than the first days or weeks of life, which increases costs and risks, according to new research published online Oct. 20 in Pediatrics.
More Reading
In the era of rapidly improving cure rates for hepatitis C infection, has the importance of staging as part of treatment diminished?